|
Real-time Estimate
Cboe BZX
08:49:24 04/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 10.72 USD | +0.70% |
|
+3.23% | -11.90% |
| 19/08 | Ocular Therapeutix, Inc. - Special Call | |
| 04/08 | Ocular Therapeutix's NDA Plans for Axpaxli in Wet AMD Remain on Track, RBC Says | MT |
| Market Cap | 233.67Cr 201.05Cr 188.67Cr 172.62Cr 322.18Cr 22TCr 324.73Cr 2.23TCr 869.19Cr 11TCr 877.48Cr 858.34Cr 36TCr | P/E 2026 * |
-7.14x | P/E 2027 * | -7.64x |
|---|---|---|---|---|---|
| Enterprise Value | 195.87Cr 168.53Cr 158.15Cr 144.69Cr 270.06Cr 19TCr 272.2Cr 1.87TCr 728.58Cr 9.46TCr 735.54Cr 719.49Cr 30TCr | EV / Sales 2026 * |
37x | EV / Sales 2027 * | 22.2x |
| Free-Float |
99.07% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| OCUL | Delayed | |
CBOE
| OCUL | Real-time | |
|
Tradegate
| 0OT | Real-time | |
|
Deutsche Boerse AG
| 0OT | Delayed | |
|
Börse Stuttgart
| 0OT | Delayed | |
|
Boerse Muenchen
| 0OT | Real-time | |
|
Berne S.E.
| 0OT | End-of-day quote |
Last Transcript : Ocular Therapeutix, Inc.
| 1 day | +0.80% | ||
| 1 week | +3.23% | ||
| Current month | +1.95% | ||
| 1 month | +24.51% | ||
| 3 months | +21.53% | ||
| 6 months | -3.12% | ||
| Current year | -11.90% |
| 1 week | 10.13 |  | 11.08 |
| 1 month | 8.4 | | 11.74 |
| Current year | 6.23 | | 13.03 |
| 1 year | 6.23 | | 16.44 |
| 3 years | 2 | | 16.44 |
| 5 years | 2 | | 16.44 |
| 10 years | 2 | | 24.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pravin Dugel
CEO | Chief Executive Officer | 62 | 15/04/2024 |
Jason Robins
DFI | Director of Finance/CFO | 50 | 20/01/2026 |
Nadia Waheed
CTO | Chief Tech/Sci/R&D Officer | 49 | 20/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Charles Warden
CHM | Chairman | 57 | 01/07/2019 |
| Director/Board Member | 78 | 05/11/2012 | |
Leslie Williams
BRD | Director/Board Member | 66 | 20/03/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 31/08/26 | Sell | Chief Operating Officer | -1,099 | 0.0005% | ||
| 25/08/26 | Don | Chief Executive Officer | -1,00,184 | 0.0473% | ||
| 24/08/26 | Sell | Executive/Senior Manager | -3,035 | 0.0014% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.70% | +3.23% | -15.79% | +172.83% | 233.67Cr | |
| -1.40% | -2.59% | +54.02% | +104.98% | 1,03400Cr | |
| -0.85% | +2.89% | +54.28% | +71.64% | 67TCr | |
| -1.13% | +0.57% | +20.63% | +75.87% | 46TCr | |
| +0.13% | -0.53% | +29.42% | +38.48% | 35TCr | |
| -1.07% | +5.03% | +25.06% | +45.97% | 31TCr | |
| -1.03% | +0.24% | -1.56% | +12.24% | 26TCr | |
| -1.42% | +1.23% | +56.27% | +72.32% | 24TCr | |
| -0.88% | +1.15% | -17.09% | -54.39% | 21TCr | |
| -0.64% | +3.08% | +33.16% | +99.80% | 19TCr | |
| Average | -0.76% | +0.98% | +23.84% | +63.97% | 37.19TCr | |
| Weighted average by Cap. | -1.02% | +1.04% | +36.47% | +66.57% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.29Cr 4.55Cr 4.27Cr 3.91Cr 7.3Cr 500.33Cr 7.36Cr 51Cr 20Cr 255.69Cr 20Cr 19Cr 823.47Cr | 10Cr 8.82Cr 8.27Cr 7.57Cr 14Cr 968.72Cr 14Cr 98Cr 38Cr 495.05Cr 38Cr 38Cr 1.59TCr |
| Net income | -33Cr -29Cr -27Cr -25Cr -46Cr -3.16TCr -46Cr -319.3Cr -124.35Cr -1.61TCr -125.54Cr -122.8Cr -5.2TCr | -32Cr -28Cr -26Cr -24Cr -45Cr -3.07TCr -45Cr -309.85Cr -120.67Cr -1.57TCr -121.82Cr -119.16Cr -5.05TCr |
| Net Debt | -38Cr -33Cr -31Cr -28Cr -52Cr -3.57TCr -53Cr -361.04Cr -140.6Cr -1.83TCr -141.95Cr -138.85Cr -5.88TCr | -6.6Cr -5.68Cr -5.33Cr -4.88Cr -9.1Cr -623.9Cr -9.17Cr -63Cr -25Cr -318.84Cr -25Cr -24Cr -1.03TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/26/04 | $10.71 | +0.61% | 1,79,393 |
| 03/26/03 | $10.64 | -2.39% | 21,28,709 |
| 02/26/02 | $10.90 | +3.12% | 20,68,790 |
| 01/26/01 | $10.57 | +0.76% | 15,78,326 |
| 31/26/31 | $10.49 | +1.25% | 15,20,523 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- OCUL Stock
Select your edition
All financial news and data tailored to specific country editions
